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Evaluation of changes in cerebral blood flow (CBF) in response to manipulation of 
arterial carbon dioxide tension (𝑃CO2) is a non-invasive technique to assess cerebrovascular 
function.  Hypercapnia is achieved using respiratory maneuvers that produce either transient 
or step changes in 𝑃CO2.  Although the CBF response is similar between methods, transient 
hypercapnia through rebreathing provides additional data points and allows for a more 
dynamic assessment of the relationship between CBF and end-tidal CO2 tension (𝑃ET,CO2).  
The aim of this study was to compare rebreathing and steady-state methodologies to evaluate 
population differences in the cerebral hemodynamic response to hypercapnia.  We 
hypothesized that during rebreathing, African American (AA) individuals would exhibit a 
lower maximal increase in cerebrovascular conductance (CVCI) relative to Caucasian 
Americans (CA) despite comparable cerebrovascular reactivity to CO2 (CVR), whereas during 
steady-state hypercapnia, there would be no difference between groups during inhalation of 
3% or 6% CO2, but AA would display reduced CVCI when breathing 9% CO2.  Middle 
cerebral artery blood flow velocity (CBFV) was measured using transcranial Doppler 
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ultrasound in young, healthy AA (n = 12) and CA (n = 11) participants during two conditions 
(randomized): (i) transient, breath-by-breath increases in 𝑃ET,CO2 induced by rebreathing; and 
(ii) steady-state increases in 𝑃ET,CO2  induced by inhalation of 3%, 6%, and 9% CO2.  The 
maximal increase in CVCI (CBFV/mean arterial pressure) with hypercapnia was lower in AA 
compared to CA in both methods (rebreathing, P = 0.018; steady-state, P = 0.049).  Linear 
regression of CVCI vs. 𝑃ET,CO2 during steady-state hypercapnia suggested that CVR was 
reduced in AA when the slopes from baseline (P = 0.044) or 3% (P = 0.039) through 6% CO2 
were considered, whereas logistic regression of the response to rebreathing indicated no 
difference in maximal CVR between the two groups (P = 0.59).  These results indicate that 
both rebreathing and steady-state techniques were sufficient to detect differences in the 
cerebral vasodilatory reserve capacity between populations, whereas linear regression to 
estimate CVR is influenced by the extent of hypercapnia and may inaccurately describe CVR 
when data from the asymptotic region of the response is included in analysis. 
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Introduction & Purpose 
In humans, the cerebral vasculature is tightly regulated by the partial pressure of 
carbon dioxide (𝑃CO2) in arterial circulation where cerebral perfusion increases with 
hypercapnia and decreases with hypocapnia (Kety & Schmidt, 1948; Shapiro et al., 1966).  
This sensitive response, which is largely mediated by dilation or constriction of arterioles, 
plays a key role in regulation of central pH (Lambertson et al., 1961; Ainslie & Duffin 2009).  
In research and clinical settings, the cerebral blood flow (CBF) response to manipulation of 
𝑃CO2, referred to as cerebrovascular reactivity (CVR), is used as a safe, inexpensive, and non-
invasive technique to assess cerebrovascular function.  Alterations in the relationship 
between changes in 𝑃CO2 and cerebral blood flow manifest in clinical conditions including 
carotid artery disease (Ringelstein et al., 1988), diabetes (Kadoi et al., 2003), and endothelial 
dysfunction (Lavi et al., 2006), and a diminished response predicts and may contribute to the 
development of stroke (Gur et al., 1996; Markus & Cullinane, 2001).  Thus, CVR is a practical 
tool that provides powerful insight as an index of cerebral vascular health. 
Cerebrovascular reactivity can be assessed using respiratory maneuvers that induce 
steady-state or transient changes in 𝑃CO2.  Steady-state inspiration of a series of fixed 
concentrations of CO2 is a commonly used method to elicit hypercapnia (Shapiro et al., 1966; 
Xie et al., 2005; Peebles et al. 2007).  Reactivity is then quantified using linear regression of 
the blood flow response to changes in arterial 𝑃CO2, which is often indexed using end-tidal 
CO2 tension (𝑃ET,CO2).  This technique allows sufficient time for changes in medullary 
concentration of H+ to stimulate chemoreceptor-mediated hyperventilation; thus it is used 
when integration between CBF and ventilatory responses to hypercapnia are of interest.  
Another commonly used approach is rebreathing exhaled gas, which produces breath-by-
breath increases in 𝑃CO2 (Read & Leigh, 1967; Claassen et al., 2007).  Although the 
cerebrovascular response is similar between steady-state and transient hypercapnia (Brothers 
et al., 2014), the rebreathing technique, because it produces many additional data points, 
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provides more information and allows for a more dynamic assessment of the relationship 
between CBF and 𝑃CO2.  Since this relationship is nonlinear (Ringelstein et al., 1988; Claassen 
et al., 2007), use of linear regression of steady-state data may inaccurately estimate differences 
in CVR between populations.  Additionally, depending on the concentrations employed, 
inspiration of fixed fractional CO2 may not produce a sufficient range of change in 𝑃CO2 to 
detect differences in the asymptotic region of the response when comparing groups.  
Considering these limitations, it is important to assess the sensitivity of each method to detect 
differences in CVR and cerebral vasodilatory reserve capacity between populations.   
The purpose of this study was to compare rebreathing and steady-state methodologies 
to examine the cerebral hemodynamic response to hypercapnia.  To accomplish this, we 
performed both techniques in a randomized, cross-over design in a population which our lab 
has previously shown to have a reduced vasodilatory reserve capacity when exposed to 
rebreathing-induced hypercapnia (Hurr et al., 2014).  The responses of African American 
participants were compared to those of Caucasian American participants matched by age, sex, 
and BMI.  We hypothesized that:  
1. The African American group would have a reduced maximal vasodilatory 
response to changes in 𝑃CO2 compared to the Caucasian American group during 
the rebreathing protocol despite similar cerebrovascular reactivity. 
2. The response would be similar between groups during steady-state inhalation of 
3% and 6% CO2.   
3. Extending the steady-state stimulus to 9% CO2 would improve the sensitivity of 
the technique to detect differences between groups.  
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Experimental Design & Methods 
PARTICIPANTS 
Twelve African American (AA) and eleven Caucasian American (CA) adults 
participated in this study (Table 1).  Subjects were free from known cardiovascular, 
metabolic, or neurological disease.  Participants were non-smokers and were not taking 
medications with the exception of oral contraception.  Females were studied during the early 
follicular phase of the menstrual cycle.   
Table 1: Subject Characteristics 
Variable 
African American 
(n = 12) 
Caucasian American 
(n = 11) P-Value 
Age (years) 24 ± 1 23 ± 1 0.71 
Sex (male/female) 7 / 5 7 / 4 0.87 
Height (cm) 174 ± 3 173 ± 2 0.92 
Weight (kg) 73 ± 4 68 ± 3 0.30 
BMI (kg·m-2) 24 ± 0.7 23 ± 0.4 0.07 
Values are means ± SEM.  Abbreviations: BMI, body mass index. 
ETHICAL APPROVAL 
The experimental protocol and consent process were approved by The Institutional 
Review Board at The University of Texas at Austin.  The purpose and risks of all study 
procedures were verbally explained to participants, who provided written, informed consent.  
The study conformed to provisions established by The Declaration of Helsinki. 
INSTRUMENTATION & MEASUREMENTS 
All studies took place in the morning following an overnight fast (≥12 hr) in a dimly-
lit, temperature-controlled laboratory (24ᴼC, 40% humidity).  Participants were required to 
abstain from exercise, medication, and alcohol for 24 hr prior to the experimental trial and to 
avoid consumption of food and caffeine for 12 hr prior.   
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Each subject’s right middle cerebral artery (MCA) was imaged through the temporal 
window to measure cerebral blood flow velocity using a 2 MHz transcranial Doppler (TCD) 
ultrasound probe (DWL; Compumedics), which was secured in place with a specialized 
headpiece.  Participants were fitted with an oro-nasal face mask (V2 Mask; Hans Rudolph, 
Inc.) and end-tidal CO2 was sampled using a capnograph (RespSense; Nonin Medical, Inc.).  
Beat-to-beat blood pressure was continuously monitored through a finger cuff using the 
Peňáz method (CNAP Monitor, CNSystems) and blood pressure was measured at regular 
intervals through auscultation of the brachial artery with electrosphygmomanometry 
(Tango+; Sun Tech Medical, Inc.).  Participants were instrumented with an electrocardiogram 
to record cardiac rhythms and heart rate and a pulse oximeter to monitor oxygen saturation 
(GE Dash 4000; General Health Care).      
EXPERIMENTAL PROTOCOL 
Following collection of anthropometric data, participants rested in a semi-recumbent 
position for at least 20 min while the TCD signal was optimized.   Then, subjects performed 
two breathing techniques designed to induce hypercapnia in a randomized order separated by 
20 min of rest. 
Rebreathing 
A 5 liter bag was attached to the mask using a three-way valve with a stopcock.  
Approximately 5 min prior to data collection, participants performed a deep inspiration, then 
exhaled to fill the empty bag.  The valve was returned to room air for 2 min of baseline data 
collection.  Upon switching the valve, subjects rebreathed from the bag for ~3 min.  Arterial 
oxygen saturation was maintained during the rebreathing maneuver by bleeding a small 
amount of oxygen into the bag (Claassen et al., 2007).  Subjects were instructed to continue 
rebreathing until they began to experience discomfort, at which point the valve was returned 
to room air.  
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Steady-State 
Baseline data was collected for 2 min while the mask was open to room air, then 
subjects breathed from pre-mixed gas cylinders containing 3%, 6%, and 9% CO2 for 2 min per 
step.  Each gas blend contained 21% oxygen and was balanced with nitrogen.  The cylinders 
were attached to the mask with a two-way valve. 
CALCULATIONS AND DATA ANALYSIS 
Data for cerebral blood flow velocity, blood pressure, 𝑃ET,CO2, and cardiac rhythms 
were recorded continuously at 125 Hz using a data acquisition program (Biopac System).  
Baseline values were calculated as 1 min averages, and the final 30 sec of each stage of the 
steady-state protocol were averaged for each subject.  Rebreathing data were obtained using 
breath-by-breath analysis. 
CBFV was expressed as a percentage of baseline.  Mean arterial pressure (MAP) was 
calculated from the automated blood pressure cuff measurements as diastolic blood pressure 
plus one-third pulse pressure.  To account for changes in MAP induced by hypercapnia, an 
index of cerebrovascular conductance (CVCI) was calculated as CBFV/MAP and expressed as 
a percentage of baseline.   
Values of CVCI during the rebreathing protocol were analyzed using a four parameter 
logistic regression for sigmoidal curve fitting (Kent et al. 1972; Claassen et al. 2007): 




where 𝑦0 represents the maximal value of CVCI; 𝑎 is the range of change, 𝑏 indicates the 
overall sigmoidal property of the curve, and 𝑥0 denotes the value of 𝑃ET,CO2 at which 
cerebrovascular reactivity was maximal (Figure 1).   
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Maximal cerebrovascular reactivity (CVRmax) was calculated at 𝑥 = 𝑥0 using a first-order 
derivative of the following function: 




 Linear regression of the slope of changes in CVCI in response to steady-state changes 
in 𝑃ET,CO2  was used to assess cerebrovascular reactivity (CVR).  
STATISTICAL ANALYSIS 
Statistical analyses were performed using commercially available software (SigmaPlot 
12.5; Systat Software, Inc.).  Student’s t-tests were used to evaluate subject characteristics and 
baseline values.  The sex ratio between the two groups was analyzed using a χ2 test.  
Parameters from the logistic regression, maximal values achieved during rebreathing, and 
estimates of CVR were compared using Student’s t-tests.  Two-way, repeated measures 
ANOVA was utilized to evaluate the responses of CVCI, CBFV, and MAP to the steady-state 
gas stimuli in the AA and CA groups, and post-hoc analyses were performed using Tukey’s 
HSD when appropriate.  Planned comparisons of group responses to each gas from the steady-
state protocol were performed using the Bonferroni method.  A 95% confidence interval was 




SUBJECT CHARACTERISTICS & BASELINE VALUES 
There was no difference in age, sex, height, weight, or BMI between groups (Table 1; 
P > 0.05 for all comparisons).  During the eucapnic baseline period before each stimulus, there 
was no difference in HR, MAP, 𝑃ET,CO2, CBFV, or CVCI between groups (Table 2; P > 0.05 for 
all comparisons).  Baseline 𝑃ET,CO2 was lower preceding the rebreathing trial than the steady-
state trial (40 ± 1 vs. 39 ± 1; P = 0.01), whereas HR, MAP, CBFV, and CVCI were not different 
between baselines (Table 2; P > 0.05 for all comparisons).  
Table 2: Baseline Hemodynamic Values 
 Steady-State Baseline Rebreathing Baseline 
Variable 
AA 
(n = 12) 
CA 




(n = 12) 
CA 
(n = 11) 
P-
Value 
HR (beats·min-1) 64 ± 2 61 ± 2 0.41  66 ± 2 62 ± 3 0.33 
MAP (mmHg) 92 ± 4 92 ± 3 0.95  93 ± 4 90 ± 3 0.61 
CBFV (cm·s-1) 75 ± 4 67 ± 4 0.18  75 ± 5 71 ± 3 0.45 
CVCI (cm·s-1·mmHg-1) 0.8 ± 0.1 0.7 ± 0.0 0.29  0.7 ± 0.0 0.7 ± 0.0 0.56 
𝑃ET,CO2 (mmHg) 41 ± 1 40 ± 1 0.50  40 ± 1 39 ± 1 0.63 
Values are means ± SEM.  Abbreviations: AA, African American; CA, Caucasian American; 
CBFV, velocity of blood flow in the middle cerebral artery; CVCI, index of cerebral vascular 
conductance; HR, heart rate; MAP, mean arterial pressure; and 𝑃ET,CO2, partial pressure of end-
tidal carbon dioxide. 
 
CEREBROVASCULAR RESPONSES TO HYPERCAPNIA 
Rebreathing 
Maximal CBFV and CVCI reached during rebreathing were lower in AA relative to 
CA participants (Figure 3; CBFV: AA, 151 ± 5% vs. CA, 165 ±  6%, P = 0.04; CVCI: AA, 134 ± 
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3% vs. CA, 148 ± 5%; P = 0.018).  Rebreathing increased 𝑃ET,CO2 by 17 ± 1 mmHg in AA and 
20 ± 1 mmHg in CA (P = 0.11). 
Data from three subjects were excluded from analysis of logistic function parameters 
because their responses were not adequately described by the function.  For the remaining 
subjects (AA, n = 10; CA, n = 10), logistic regression of CVCI vs. 𝑃ET,CO2 yielded a correlation 
coefficient (R2) of 0.95.  Logistic regression curves representing the responses of each group 
are illustrated in Figure 1. Both the maximal increase (𝑦0) and the total range of change (𝑎) in 
CVCI were reduced in AA compared to CA subjects (𝑦0: AA, 138 ± 4% vs. CA, 151 ± 4%; P = 
0.02; 𝑎: AA, 43 ± 5% vs. CA, 56 ± 5%; P = 0.03).  Maximal cerebrovascular reactivity (CVRmax) 
and the level of 𝑃ET,CO2 at which reactivity was maximal (𝑥0) were not different between 
groups (Table 3; CVRmax: AA, 3.7 ± 0.5%·mmHg-1 vs. CA, 4.1 ± 0.5%·mmHg-1; P = 0.59; 𝑥0: 
AA, 49 ± 2 mmHg  vs. CA, 50 ± 1 mmHg; P = 0.54). 
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Figure 1: Logistic regressions of CVCI during rebreathing 
A schematic diagram illustrating a logistic regression and its parameters is shown in panel A.  
The parameter 𝑦0 represents the maximal value of CVCI, 𝑎 is the range of change, 𝑥0 denotes 
the value of 𝑃ET,CO2 at which cerebrovascular reactivity was maximal. Group mean values of 
the four parameters observed during rebreathing are represented as logistic regression curves 
in panel B.  The parameters 𝑦0 and 𝑎 were lower in AA relative to CA participants, whereas 




















































Two participants (AA) did not complete the final stage of the steady-state protocol.  
In these subjects, CBFV appeared to have stabilized, thus data collected after 60 sec of 9% CO2 
inhalation were averaged and included in analysis.  
As shown in Figure 2, the increase in CVCI during steady-state hypercapnia was 
moderated by race (P = 0.046).  There was no difference in CVCI between groups during 3% 
CO2 inhalation (AA, 104 ± 2% vs. CA, 108 ± 2%; P = 0.42), whereas CVCI was lower in AA 
relative to CA participants during 6% and 9% CO2 inhalation (6%: AA 120 ± 4% vs. CA, 131 ± 
3%; P = 0.026; 9%: AA, 137 ± 6% vs. CA, 152 ± 6%; P = 0.006).  The maximal increase in 
CVCI observed during steady-state hypercapnia was lower in AA than CA participants 
(Figure 3; AA, 137 ± 6% vs. CA, 152 ± 5%, P = 0.049).  The magnitude of hypercapnia reached 
during each stage was similar between groups (𝑃ET,CO2; P = 0.43).   
The overall response of CBFV to steady-state hypercapnia was not different between 
groups (P = 0.10).  However, planned comparisons for each gas mixture revealed lower CBFV 
in AA compared to CA participants during inhalation of 9% CO2 (AA, 158 ± 6% vs. CA, 175 ± 
8%; P = 0.006).  MAP increased with hypercapnia (P < 0.001) to a similar degree between 
groups (P = 0.83). 
Estimates of CVR obtained from steady-state data are recorded in Table 3.  Stepwise 
linear regression revealed no difference in CVCI reactivity from baseline to 3% CO2 
inhalation or from 6% to 9% CO2.  However, reactivity was reduced in AA when the slopes 
from 3% to 6% CO2 inhalation were compared.  When multiple data points were included in 
slope calculations, CVR was lower in AA compared to CA from baseline through 6% CO2, but 
there was not a difference in CVR between groups upon regression of all data from 
baseline through 9% CO2.   
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Figure 2: CVCI during steady-state hypercapnia 
The response of CVCI to steady-state hypercapnia was moderated by race (group by CO2 
interaction; P = 0.046) such that there was no difference between groups when 3% CO2 was 
inhaled, but CVCI increased to a lesser degree in AA compared to CA upon inhalation of 6% 

























P = 0.026 
P = 0.006 
NS 
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Table 3: Estimates of Cerebrovascular Reactivity to Carbon Dioxide 
Analysis AA CA P-Value 
Rebreathing    
Logistic Function:    
CVRmax at 𝑥 = 𝑥0 (%·mmHg-1) 3.7 ± 0.5 4.1 ± 0.5 0.59 
Steady-State    
Stepwise Linear Regression:    
Baseline to 3% CO2 (%·mmHg-1)  1.0 ± 0.6 2.1 ± 0.5 0.20 
3% CO2 to 6% CO2 (%·mmHg-1) 1.9 ± 0.4* 3.1 ± 0.4 0.04 
6% CO2 to 9% CO2 (%·mmHg-1) 1.3 ± 0.2 1.5 ± 0.3 0.56 
Least Squares Regression:    
Baseline through 6% CO2 (%·mmHg-1) 1.7 ± 0.4* 2.7 ± 0.3 0.04 
Baseline through 9% CO2 (%·mmHg-1) 1.5 ± 0.2 2.0 ± 0.2 0.11 
Values are means ± SEM.  Abbreviations: AA, African American; CA, Caucasian 
American; CVRmax maximal cerebrovascular reactivity.  *P < 0.05 vs. CA.  
 
 
Figure 3: Group differences in the maximal increase in CVCI 
The maximal increase in CVCI was lower in AA relative to CA during rebreathing and 

























The present comparison of rebreathing and steady-state techniques to assess 
cerebrovascular responses to hypercapnia revealed that each method was sufficient to detect 
differences between the responses of healthy, college-aged African American and Caucasian 
American subjects.  Both techniques showed similar responses between groups at low levels 
of hypercapnia with differences emerging as 𝑃ET,CO2 progressed.  These findings provide 
insight to group variations in the dynamic relationship between cerebral blood flow and 
𝑃ET,CO2 with implications for selecting the source and magnitude of hypercapnia and 
interpreting assessments of cerebrovascular reactivity. 
GROUP RESPONSES TO HYPERCAPNIA 
As depicted in Figure 1B, the cerebrovascular responses to rebreathing were similar 
between AA and CA participants until 𝑃ET,CO2 reached ~50 mmHg (an increase of ~10 mmHg 
from baseline).  Beyond this point, the responses diverged and revealed a lower maximal 
increase in CVCI in AA compared to CA subjects.  Cerebrovascular reactivity was similar 
between groups, while the maximal increase and range of change were reduced in AA.  These 
results suggest that, despite equivalent cerebrovascular sensitivity to hypercapnia, AA 
individuals exhibit a lower cerebral vasodilatory reserve capacity than their CA counterparts. 
The cerebrovascular responses to steady-state hypercapnia were similar between 
groups during inhalation of 3% CO2, which elicited a 𝑃ET,CO2 of 44 mmHg (Figure 2).  When 
the stimulus was raised to 6% and 9% CO2, which produced 𝑃ET,CO2 values of 52 and 66 
mmHg, respectively, a distinction emerged between groups in which AA participants 
exhibited a smaller increase in CVCI than CA participants.  Although we hypothesized that 
the response to 6% CO2 would be comparable in AA and CA, these results align with our 
findings from the rebreathing protocol, which suggest that the group responses begin to 
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separate when 𝑃ET,CO2 is ~50 mmHg.  Thus, we speculate that 6% CO2 was a sufficient 
stimulus to detect differences between these groups, whereas commonly-used intermediate 
concentrations of 4% or 5% CO2 (Ringelstein et al., 1988; Xie et al., 2005) would likely fail to 
catch group differences. 
CEREBRAL VASODILATORY CAPACITY & REACTIVITY  
The maximal increase in CVCI was reduced in AA relative to CA participants 
regardless of the technique or analysis employed (Figure 3).  This finding is in agreement with 
previous results from our lab which demonstrated a lower vasodilatory reserve capacity in 
young African Americans in response to hypercapnic rebreathing (Hurr et al., 2014).  
However, estimates of cerebrovascular reactivity varied depending on the analysis used 
(Table 3).  Linear regression of the response to steady-state hypercapnia suggested that CVR 
was reduced in AA when the slopes from baseline or 3% through 6% CO2 were considered, 
whereas logistic regression of the response to rebreathing indicated no difference in CVRmax 
between the two groups.  These results suggest that estimates of CVCI-CO2 sensitivity are 
influenced by the method of analysis and combination of data points examined.  Since CVCI 
exhibits a sigmoidal response to changes in 𝑃ET,CO2 (Ringelstein et al., 1988; Claassen et al., 
2007), linear regression of steady-state data likely underestimates true CVR when values from 
the asymptotic region of the response are included in calculations.   
LIMITATIONS 
The diameter of the insonated vessel cannot be obtained through transcranial Doppler 
measurements; thus, CBFV only accurately reflects CBF if the cross-sectional area of the 
middle cerebral artery remains constant during hypercapnia.  This assumption has been 
inconclusively debated in recent years.  Previous studies have concluded that the diameter is 
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not altered during moderate changes in plasma CO2 tension such as those induced by 
inhalation of 6% CO2 (Bradac et al., 1976; Poulin & Robbins, 1996; Serrador et al., 2000), 
while others have challenged these findings (Willie et al., 2012; Coverdale et al., 2014).  If the 
hypercapnic stimuli in the present study did result in dilation of the MCA, it is possible that 
CBFV measurements underestimated CBF.  However, considering the similar blood pressure 
responses observed in our groups, any discrepancy between CBFV and CBF is likely 
comparable between AA and CA.  Further characterization with more sophisticated imaging 
modalities is warranted to examine the source and physiological significance of the 
differences in cerebrovascular reserve capacity.        
The degree of hypercapnia was assessed through measurement of 𝑃ET,CO2  rather than 
arterial or venous 𝑃CO2 .  At high levels, 𝑃ET,CO2 has been shown to overestimate arterial 
𝑃CO2 (Peebles et al., 2007).  However, adjusting our 𝑃ET,CO2 values to better approximate 
arterial 𝑃CO2 according to the method developed by Peebles et al. (2007) did not alter our 
findings; thus, we feel that 𝑃ET,CO2 provided a valid index for interpretation of the 
cerebrovascular response to hypercapnia.  𝑃ET,CO2 was 1 mmHg higher during the 
normocapnic baseline period preceding the steady-state trial than before  rebreathing, which 
is likely an artifact of the different valves employed.  This is supported by the equivalent 
CBFV and CVCI measurements during the baseline periods. 
CONCLUSIONS 
In conclusion, we observed that rebreathing and steady-state hypercapnia were each 
sufficient to detect differences in the maximal increase in cerebrovascular conductance 
between healthy, young African American and Caucasian American participants.  Estimates 
of cerebrovascular reactivity to hypercapnia differed depending on the method of analysis 
employed, and it is likely that linear regression inaccurately represents true reactivity when 
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analysis includes values from the asymptotic region of the response to CO2.  These findings 
provide insight for selection of an appropriate hypercapnic stimulus to examine group 
differences in cerebrovascular reserve capacity versus cerebrovascular reactivity.  Further 
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